INTRODUCTION
The prevalence of marijuana use has doubled in the past decade. One in eight US adults now reports use of marijuana in the past year. 1 Despite increasing use, our understanding of the risks and benefits of marijuana use is limited. [1] [2] [3] The National Academy of Sciences, editorials, and numerous systematic reviews have called for more research. [1] [2] [3] Despite concerns within the scientific community, only 33% of the public perceive Bgreat risk^from weekly marijuana use compared to 50% in 2002. 1 The public appears to believe that recreational marijuana use is safe and even has health benefits. 1 The media contributes greatly to the national perspective on health 4 but may provide incomplete information. 4 We examined a cross-section of news media coverage to better understand how the media may influence the public's view of marijuana.
METHODS
We identified the top 10 major news outlets by print circulation using Pew's 2014 ranking. 5 We selected those with articles available on LexisNexis, including The New York Times, The Daily News New York, The New York Post, The Denver Post, USA Today, and the Los Angeles Times; these have a combined total of approximately 4.9 million daily visitors.
We selected articles published between 1/1/12 (Colorado's recreational legalization) and 5/1/2016 (the study's initiation date), with major subject Bmarijuana.^If more than 100 articles were available from any publication, 100 were randomly selected. We excluded articles < 100 words, editorials, and those without a marijuana focus. One reviewer (AW or RA) categorized each article by focus health, business, public policy, crime, and entertainment/other and flagged them for health mentions. Each article with a mention was abstracted independently by two reviewers (AZ, RA) for overall message content. Overall content was categorized as follows: (1) marijuana benefits outweigh harms, (2) marijuana harms outweigh benefits, or (3) neutral impression of harms vs. benefits. Disagreements were adjudicated by a third abstractor (AA). We analyzed the relationship between the article's overall slant and other characteristics using descriptive statistics.
Data Availability. Dataset available from corresponding author on request.
RESULTS
We identified 564 articles of which 477 met inclusion criteria. Articles' focus were categorized as public policy (n = 190, 39.8%), crime (n = 113, 23.7%), business (n = 74, 15.5%), entertainment/other (n = 69, 14.5%), and health (n = 31, 6.5%). Health mentions were found in a third of articles (n = 145, 30.4%), of which 89 (61.3%) mentioned health benefits, and 98 (67.5%) mentioned harms (Table 1) . About half of articles with health mentions (n = 72, 49.7%) communicated a favorable impression of marijuana (net benefit), 46 (31.7%) communicated a negative impression (net harm), and 27 (18.6%) were neutral. Articles that were not focused on health were more likely to communicate a favorable impression of marijuana (p < .001). Of the 31 articles that were focused on health and public health, 13 (41.9%) acknowledged weaknesses in the evidence base surrounding marijuana while 18 (58.1%) did not. Articles discussing both benefits and harms were more likely to communicate a favorable impression of marijuana (p < .001). The proportion of articles with favorable mentions of marijuana increased from 11.1% in 2012 to 65% in 2016.
DISCUSSION
Most articles on marijuana do not mention health effects. Nearly half of articles in our sample that mentioned health Ann Abraham and Alysandra J. Zhang contributed to work equally and are considered co-first authors.
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effects communicated a favorable impression of marijuana. Articles that focused exclusively on health-related issues of marijuana were more likely to communicate a nuanced view on marijuana use; however, these articles represented a small portion of all marijuana articles (6.5%, 31/477). Articles covering public policy and business aspects of recreational legalization tended to communicate more benefits than harms. Given that many reported therapeutic benefits have insufficient evidence, 2,3 the media's coverage slant is concerning and may lead the public to underestimate health risks associated with frequent marijuana use. 1, 6 Our study has limitations that deserve comment. Top print circulation newspapers are dominated by coastal outlets whose favorable messaging may not be generalizable. On the other hand, the newspapers included have an outsized influence on public discourse. In addition, print has declined in relation to digital media. However, while our sampling strategy relied on print articles, these articles are also available in digital format on news websites and widely shared in social media.
In conclusion, major news outlets communicate a more positive message regarding marijuana use than is warranted by current evidence. A concerted public health response is needed to counter the inaccurate information provided to the public.
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